Skip to main content
Erschienen in: International Journal of Colorectal Disease 12/2016

21.09.2016 | Original Article

Association between pathologic features of peripheral nerves and postoperative anal function after neoadjuvant therapy for low rectal cancer

Erschienen in: International Journal of Colorectal Disease | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Neoadjuvant chemoradiotherapy (CRT) for rectal cancer improves local control but also induces severe postoperative anal dysfunction that may be related to neural degeneration. The aims of the study were to identify pathological features of neural degeneration caused by neoadjuvant CRT or neoadjuvant chemotherapy (NAC) and to evaluate the association between neural degeneration and anal function.

Methods

A retrospective study using chronologically different groups was performed in 95 patients with rectal cancer treated with curative resection with neoadjuvant CRT (n = 47), NAC (n = 27), or surgery alone (no neoadjuvant therapy) (n = 21) at National Cancer Center Hospital East from 2001 to 2014. Peripheral nerve degeneration was evaluated histopathologically using H&E stained sections, based on karyopyknosis, vacuolar or acidophilic degeneration, denucleation, adventitial neuron change, and fibrosis. Morphological analysis of peripheral nerves was compared among the three groups. The association between pathological features and anal function (Wexner Score) was evaluated.

Results

After CRT, the degree of fibrosis around the tumor was severe, and neural degeneration was found in peripheral neurons. With NAC and surgery alone, there was little fibrosis and neural degeneration. Pathological changes after CRT were more pronounced than those after NAC, indicating greater tissue degeneration due to CRT. There was an association between anal function and degeneration score in the CRT group, but not in the other groups.

Conclusions

Peripheral nerves in patients who received neoadjuvant CRT showed characteristic pathological features indicating greater degeneration, compared with patients who received NAC. Neural degeneration is associated with anal function and several pathological factors after CRT.
Literatur
1.
Zurück zum Zitat Paty PB, Enker WE, Cohen AM, Lauwers GY (1994) Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg 219:365–373CrossRefPubMedPubMedCentral Paty PB, Enker WE, Cohen AM, Lauwers GY (1994) Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg 219:365–373CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Schiessel R, Karner-Hanusch J, Herbst F, Teleky B, Wunderlich M (1994) Intersphincteric resection for low rectal tumours. Br J Surg 81:1376–1378CrossRefPubMed Schiessel R, Karner-Hanusch J, Herbst F, Teleky B, Wunderlich M (1994) Intersphincteric resection for low rectal tumours. Br J Surg 81:1376–1378CrossRefPubMed
3.
Zurück zum Zitat Saito N, Sugito M, Ito M, Kobayashi A, Nishizawa Y, Yoneyama Y, Nishizawa Y, Minagawa N (2009) Oncologic outcome of intersphincteric resection for very low rectal cancer. World J Surg 33:1750–1756. doi:10.1007/s00268-009-0079-2 CrossRefPubMed Saito N, Sugito M, Ito M, Kobayashi A, Nishizawa Y, Yoneyama Y, Nishizawa Y, Minagawa N (2009) Oncologic outcome of intersphincteric resection for very low rectal cancer. World J Surg 33:1750–1756. doi:10.​1007/​s00268-009-0079-2 CrossRefPubMed
4.
Zurück zum Zitat Gamagami RA, Liagre A, Chiotasso P, Istvan G, Lazorthes F (1999) Coloanal anastomosis for distal third rectal cancer: prospective study of oncologic results. Dis Colon rectum 42:1272–1275 Gamagami RA, Liagre A, Chiotasso P, Istvan G, Lazorthes F (1999) Coloanal anastomosis for distal third rectal cancer: prospective study of oncologic results. Dis Colon rectum 42:1272–1275
5.
Zurück zum Zitat Hohenberger W, Merkel S, Matzel K, Bittorf B, Papadopoulos T, Gohl J (2006) The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence. Color Dis 8:23–33. doi:10.1111/j.1463-1318.2005.00839.x CrossRef Hohenberger W, Merkel S, Matzel K, Bittorf B, Papadopoulos T, Gohl J (2006) The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence. Color Dis 8:23–33. doi:10.​1111/​j.​1463-1318.​2005.​00839.​x CrossRef
6.
Zurück zum Zitat Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT (2001) Rectal cancer: local recurrence after surgery without radiotherapy. Dis Colon rectum 44:374–379 Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT (2001) Rectal cancer: local recurrence after surgery without radiotherapy. Dis Colon rectum 44:374–379
7.
Zurück zum Zitat Rullier E, Laurent C, Bretagnol F, Rullier A, Vendrely V, Zerbib F (2005) Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg 241:465–469CrossRefPubMedPubMedCentral Rullier E, Laurent C, Bretagnol F, Rullier A, Vendrely V, Zerbib F (2005) Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg 241:465–469CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Rullier E, Zerbib F, Laurent C, Bonnel C, Caudry M, Saric J, Parneix M (1999) Intersphincteric resection with excision of internal anal sphincter for conservative treatment of very low rectal cancer. Dis Colon rectum 42:1168–1175 Rullier E, Zerbib F, Laurent C, Bonnel C, Caudry M, Saric J, Parneix M (1999) Intersphincteric resection with excision of internal anal sphincter for conservative treatment of very low rectal cancer. Dis Colon rectum 42:1168–1175
9.
Zurück zum Zitat Saito N, Ono M, Sugito M, Ito M, Morihiro M, Kosugi C, Sato K, Kotaka M, Nomura S, Arai M, Kobatake T (2004) Early results of intersphincteric resection for patients with very low rectal cancer: an active approach to avoid a permanent colostomy. Dis Colon rectum 47:459–466. doi:10.1007/s10350-003-0088-4 Saito N, Ono M, Sugito M, Ito M, Morihiro M, Kosugi C, Sato K, Kotaka M, Nomura S, Arai M, Kobatake T (2004) Early results of intersphincteric resection for patients with very low rectal cancer: an active approach to avoid a permanent colostomy. Dis Colon rectum 47:459–466. doi:10.​1007/​s10350-003-0088-4
10.
Zurück zum Zitat Kohler A, Athanasiadis S, Ommer A, Psarakis E (2000) Long-term results of low anterior resection with intersphincteric anastomosis in carcinoma of the lower one-third of the rectum: analysis of 31 patients. Dis Colon rectum 43:843–850 Kohler A, Athanasiadis S, Ommer A, Psarakis E (2000) Long-term results of low anterior resection with intersphincteric anastomosis in carcinoma of the lower one-third of the rectum: analysis of 31 patients. Dis Colon rectum 43:843–850
11.
Zurück zum Zitat Ito M, Saito N, Sugito M, Kobayashi A, Nishizawa Y, Tsunoda Y (2009) Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer. Dis Colon rectum 52:64–70. doi:10.1007/DCR.0b013e31819739a0 Ito M, Saito N, Sugito M, Kobayashi A, Nishizawa Y, Tsunoda Y (2009) Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer. Dis Colon rectum 52:64–70. doi:10.​1007/​DCR.​0b013e31819739a0​
13.
Zurück zum Zitat Lim JF, Tang CL, Seow-Choen F, Heah SM (2005) Prospective, randomized trial comparing intraoperative colonic irrigation with manual decompression only for obstructed left-sided colorectal cancer. Dis Colon rectum 48:205–209. doi:10.1007/s10350-004-0803-9 Lim JF, Tang CL, Seow-Choen F, Heah SM (2005) Prospective, randomized trial comparing intraoperative colonic irrigation with manual decompression only for obstructed left-sided colorectal cancer. Dis Colon rectum 48:205–209. doi:10.​1007/​s10350-004-0803-9
14.
Zurück zum Zitat Chen FC, Mackay JR, Woods RJ, Collopy BT, Fink RJ, Guiney MJ (1995) Early experience with postoperative adjuvant chemoradiation for rectal carcinoma: focus on morbidity. Aust N Z J Surg 65:732–736CrossRefPubMed Chen FC, Mackay JR, Woods RJ, Collopy BT, Fink RJ, Guiney MJ (1995) Early experience with postoperative adjuvant chemoradiation for rectal carcinoma: focus on morbidity. Aust N Z J Surg 65:732–736CrossRefPubMed
15.
Zurück zum Zitat Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Illstrup DM (1994) The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 220:676–682CrossRefPubMedPubMedCentral Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Illstrup DM (1994) The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 220:676–682CrossRefPubMedPubMedCentral
16.
17.
Zurück zum Zitat Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial. Lancet 371:1007–1016. doi:10.1016/s0140-6736(08)60455-9 CrossRefPubMedPubMedCentral Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial. Lancet 371:1007–1016. doi:10.​1016/​s0140-6736(08)60455-9 CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Rothenberg ML, Cox JV, Butts C, Navarro M, Bang YJ, Goel R, Gollins S, Siu LL, Laguerre S, Cunningham D (2008) Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. Ann Oncol 19:1720–1726. doi:10.1093/annonc/mdn370 CrossRefPubMed Rothenberg ML, Cox JV, Butts C, Navarro M, Bang YJ, Goel R, Gollins S, Siu LL, Laguerre S, Cunningham D (2008) Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. Ann Oncol 19:1720–1726. doi:10.​1093/​annonc/​mdn370 CrossRefPubMed
19.
Zurück zum Zitat Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, Tebbutt N, Hill M, Ross PJ, Massey A, Oates J (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 24:668–674. doi:10.1200/jco.2005.04.4875 CrossRefPubMed Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, Tebbutt N, Hill M, Ross PJ, Massey A, Oates J (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 24:668–674. doi:10.​1200/​jco.​2005.​04.​4875 CrossRefPubMed
20.
Zurück zum Zitat Nishizawa Y, Fujii S, Saito N, Ito M, Ochiai A, Sugito M, Kobayashi A, Nishizawa Y (2011) The association between anal function and neural degeneration after preoperative chemoradiotherapy followed by intersphincteric resection. Dis Colon rectum 54:1423–1429. doi:10.1097/DCR.0b013e31822c94e6 Nishizawa Y, Fujii S, Saito N, Ito M, Ochiai A, Sugito M, Kobayashi A, Nishizawa Y (2011) The association between anal function and neural degeneration after preoperative chemoradiotherapy followed by intersphincteric resection. Dis Colon rectum 54:1423–1429. doi:10.​1097/​DCR.​0b013e31822c94e6​
21.
Zurück zum Zitat Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Color Dis 12:19–23CrossRef Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Color Dis 12:19–23CrossRef
22.
Zurück zum Zitat Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Micciche F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C (2005) The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62:752–760. doi:10.1016/j.ijrobp.2004.11.017 CrossRefPubMed Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Micciche F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C (2005) The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62:752–760. doi:10.​1016/​j.​ijrobp.​2004.​11.​017 CrossRefPubMed
24.
Zurück zum Zitat Nishizawa Y, Fujii S, Saito N, Ito M, Nakajima K, Ochiai A, Sugito M, Kobayashi A, Nishizawa Y (2012) Differences in tissue degeneration between preoperative chemotherapy and preoperative chemoradiotherapy for colorectal cancer. Int J Colorect Dis 27:1047–1053. doi:10.1007/s00384-012-1434-6 CrossRef Nishizawa Y, Fujii S, Saito N, Ito M, Nakajima K, Ochiai A, Sugito M, Kobayashi A, Nishizawa Y (2012) Differences in tissue degeneration between preoperative chemotherapy and preoperative chemoradiotherapy for colorectal cancer. Int J Colorect Dis 27:1047–1053. doi:10.​1007/​s00384-012-1434-6 CrossRef
25.
Zurück zum Zitat Choong NW, Mauer AM, Haraf DC, Ferguson MK, Sandler AB, Kesler KA, Fishkin PA, Ansari RH, Wade J III, Krauss SA, Sciortino DF, Posner MC, Kocherginsky M, Hoffman PC, Szeto L, Vokes EE (2011) Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol 28(Suppl 1):S152–S161CrossRefPubMed Choong NW, Mauer AM, Haraf DC, Ferguson MK, Sandler AB, Kesler KA, Fishkin PA, Ansari RH, Wade J III, Krauss SA, Sciortino DF, Posner MC, Kocherginsky M, Hoffman PC, Szeto L, Vokes EE (2011) Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol 28(Suppl 1):S152–S161CrossRefPubMed
26.
Zurück zum Zitat Shimoda T, Koizumi W, Tanabe S, Higuchi K, Sasaki T, Nakayama N, Azuma M, Saigenji K, Katou T, Ogino M (2006) Small-cell carcinoma of the esophagus associated with a paraneoplastic neurological syndrome: a case report documenting a complete response. Jpn J Clin Oncol 36:109–112CrossRefPubMed Shimoda T, Koizumi W, Tanabe S, Higuchi K, Sasaki T, Nakayama N, Azuma M, Saigenji K, Katou T, Ogino M (2006) Small-cell carcinoma of the esophagus associated with a paraneoplastic neurological syndrome: a case report documenting a complete response. Jpn J Clin Oncol 36:109–112CrossRefPubMed
27.
Zurück zum Zitat Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Segawa Y, Tsujino K, Negoro S, Fuwa N, Hida T, Kawahara M, Katakami N, Hirokawa K, Yamamoto N, Fukuoka M, Ariyoshi Y (2007) Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung cancer (WJTOG-0002). Int J Radiat Oncol Biol Phys 69:786–792CrossRefPubMed Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Segawa Y, Tsujino K, Negoro S, Fuwa N, Hida T, Kawahara M, Katakami N, Hirokawa K, Yamamoto N, Fukuoka M, Ariyoshi Y (2007) Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung cancer (WJTOG-0002). Int J Radiat Oncol Biol Phys 69:786–792CrossRefPubMed
28.
Zurück zum Zitat Kaplan B, Altynbas M, Eroglu C, Karahacioglu E, Er O, Ozkan M, Bilgin M, Canoz O, Gulmez I, Gulec M (2004) Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small-cell lung cancer (NSCLC). Am J Clin Oncol 27:603–610CrossRefPubMed Kaplan B, Altynbas M, Eroglu C, Karahacioglu E, Er O, Ozkan M, Bilgin M, Canoz O, Gulmez I, Gulec M (2004) Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small-cell lung cancer (NSCLC). Am J Clin Oncol 27:603–610CrossRefPubMed
Metadaten
Titel
Association between pathologic features of peripheral nerves and postoperative anal function after neoadjuvant therapy for low rectal cancer
Publikationsdatum
21.09.2016
Erschienen in
International Journal of Colorectal Disease / Ausgabe 12/2016
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-016-2640-4

Weitere Artikel der Ausgabe 12/2016

International Journal of Colorectal Disease 12/2016 Zur Ausgabe

Letter to the Editor

Pudendal nerve testing

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.